This is the first article from a mainstream source that finally reports what we’ve been saying all along:
If, like public health authorities in the U.S. and many other countries, you’re counting on the anti-viral drug Tamiflu (generic name oseltamivir) to save you should bird flu become pandemic, you may have to think again. A Hong Kong expert told Reuters on Friday that a strain of the H5N1 virus isolated in northern Vietnam this year is resistant to Tamiflu. More common human flu viruses have also recently been shown to be developing a resistance to another set of antivirals called adamantine drugs.
If the Vietnam report proves true, the implications will be particularly worrisome for public health programs to combat bird flu: Many governments have made stockpiling Tamiflu the centerpiece of their planning for a possible pandemic. U.S. Health and Human Services Secretary Michael Leavitt wants to create a big enough stockpile to treat 20 million Americans, and about $3 billion of the $4 billion the U.S. Senate last week proposed allocating to the Centers for Disease Control and Prevention to prepare for bird flu is to be used to buy Tamiflu. Never mind the fact that Tamiflu is produced in only one facility in the world, which is unlikely to produce enough to fill everyone’s stockpile for several more years.
Think about the implications of that. The government’s preparation for the coming avian flu pandemic is to spend 75% of its budget for the crisis on a marginally effective drug that will only be available to about 7% of us.
What do you want to bet that all of that supply will be stashed in underground Continuity of Government bunkers?